Fourni par Blogger.

By Sharlene Fleming


Shock is among the initial reactions of people when they hear about cancer. It is a disease that is never taken lightly by many people. There are many who just could not accept it right away. There is that sense of desperation as they want to still live longer. It often comes with the thought of the end coming sooner than they expected. But scientific research proves to be very vital. More treatment options are being studied and among those is clodronate liposome.

Cancer results when the cells grow frantically. It could be associated with over a hundred disease types. The types are classified by the first body part or type that it affects. When these cells multiply very fast, the body would be affected. There will be masses that would form and tumors could also result. But leukemia which affects the blood is different. Because of the cells dividing in the blood stream, the blood flow will be affected.

Initially, patients will be shocked about the whole thing. They may feel that they are just counting the hours. They cannot always dismiss the fact that their time may be limited. But then there are different treatments available and they can bank on these. The advancements have made it possible for specialists to choose other treatment options.

Because of technology, there are more options available. The human genome has been decoded in a way and this leads to treatment methods being developed. This time, most of the diseases are being cured. Various other things that the experts did not anticipate also surfaced. These things are very important in giving the treatment that is necessary for patients.

Clodronate liposome or clodronip is composed of non-toxic biophosphonate. It is then partnered with artificial lipisode. This combination will trap molecules. With that, the macrophage cells could consume it. This leads to some surprising discoveries and often makes people feel more hopeful.

Many researchers noticed the suppression of the macrophage cells. These are considered in autoimmune conditions. Having these suppressed is considered an advancement also in the treatment of HIV. There are still tests to be made to prove that.

The experts see that it is more favorable if this would be administered through the trachea. It would be easier to absorb as it reaches the lungs and is absorbed in the blood stream. There is just one problem that the experts noticed. It seems that the cells die within the esophagus.

If this study continuous to provide good results, it could lead to the cure of some serious diseases. This could also mean that a new light of hope is set for patients. They would often believe that they are no longer surviving the challenge.

Development and various studies by experts could prove to be fruitful. It may take some time before clodronate liposome would be accepted medically. It would still go through a lot of tests before the whole medical community would use it for their patients. But such improvement is a good start.




About the Author: